1. Bendamustine followed by obinutuzumab and venetoclax in chronic lymphocytic leukaemia (CLL2-BAG): primary endpoint analysis of a multicentre, open-label, phase 2 trial. Issue 9 (September 2018) Authors: Cramer, Paula; von Tresckow, Julia; Bahlo, Jasmin; Robrecht, Sandra; Langerbeins, Petra; Al-Sawaf, Othman; Engelke, Anja; Fink, Anna-Maria; Fischer, Kirsten; Tausch, Eugen; Seiler, Till; Fischer von Weikersthal, Ludwig; Hebart, Holger; Kreuzer, Karl-Anton; Böttcher, Sebastian; Ritgen, Matthias; K... Journal: Lancet oncology Issue: Volume 19:Issue 9(2018) Page Start: 1215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Consensus molecular subtypes in metastatic colorectal cancer treated with sequential versus combined fluoropyrimidine, bevacizumab and irinotecan (XELAVIRI trial). (November 2021) Authors: Stahler, Arndt; Heinemann, Volker; Schuster, Veronika; Heinrich, Kathrin; Kurreck, Annika; Gießen-Jung, Clemens; Fischer von Weikersthal, Ludwig; Kaiser, Florian; Decker, Thomas; Held, Swantje; Graeven, Ullrich; Schwaner, Ingo; Denzlinger, Claudio; Schenk, Michael; Neumann, Jens; Kirchner, Thomas... Journal: European journal of cancer Issue: Volume 157(2021) Page Start: 71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Corrigendum to 'Single-nucleotide variants, tumour mutational burden and microsatellite instability in patients with metastatic colorectal cancer: Next-generation sequencing results of the FIRE-3 trial'. [European Journal of Cancer 137 (2020) 250–259]. (July 2022) Authors: Stahler, Arndt; Stintzing, Sebastian; von Einem, Jobst C.; Westphalen (Benedikt), Christoph B.; Heinrich, Kathrin; Krämer, Nicole; Michl, Marlies; Modest, Dominik P.; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kiani, Alexander; Heintges, Tobias; Kahl, Christoph; Kullmann, Frank; Scheithauer... Journal: European journal of cancer Issue: Volume 169(2022) Page Start: 223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Early tumor shrinkage in metastatic colorectal cancer: Retrospective analysis from an irinotecan‐based randomized first‐line trial. Issue 6 (15th April 2013) Authors: Giessen, Clemens; Laubender, Ruediger P.; Fischer von Weikersthal, Ludwig; Schalhorn, Andreas; Modest, Dominik P.; Stintzing, Sebastian; Haas, Michael; Mansmann, Ulrich R.; Heinemann, Volker Journal: Cancer science Issue: Volume 104:Issue 6(2013:Jun.) Page Start: 718 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. First-line fluoropyrimidine plus bevacizumab followed by irinotecan-escalation versus initial fluoropyrimidine, irinotecan and bevacizumab in patients with metastatic colorectal cancer – Final survival and per-protocol analysis of the randomised XELAVIRI trial (AIO KRK 0110). (September 2022) Authors: Stahler, Arndt; Modest, Dominik P.; Fischer von Weikersthal, Ludwig; Kaiser, Florian; Decker, Thomas; Held, Swantje; Graeven, Ullrich; Schwaner, Ingo; Denzlinger, Claudio; Schenk, Michael; Kurreck, Annika; Heinrich, Kathrin; Gießen-Jung, Clemens; Neumann, Jens; Kirchner, Thomas; Jung, Andreas; St... Journal: European journal of cancer Issue: Volume 173(2022) Page Start: 194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. First‐line nab‐paclitaxel plus carboplatin for patients with advanced non‐small cell lung cancer: Results of the NEPTUN study. (20th October 2021) Authors: Dechow, Tobias; Riera‐Knorrenschild, Jorge; Hackanson, Björn; Janssen, Jan; Schulz, Holger; Chiabudini, Marco; Fischer von Weikersthal, Ludwig; Budweiser, Stephan; Nacke, Axel; Taeuscher, Dagmar; Welslau, Manfred; Potthoff, Karin Journal: Cancer medicine Issue: Volume 10:Number 22(2021) Page Start: 8127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Gender-dependent survival benefit from first-line irinotecan in metastatic colorectal cancer. Subgroup analysis of a phase III trial (XELAVIRI-study, AIO-KRK-0110). (April 2021) Authors: Heinrich, Kathrin; Modest, Dominik P.; Ricard, Ingrid; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kaiser, Florian; Graeven, Ullrich; Uhlig, Jens; Schenk, Michael; Freiberg-Richter, Jens; Peuser, Bettina; Denzlinger, Claudio; Giessen-Jung, Clemens; Stahler, Arndt; Michl, Marlies; Held, Swant... Journal: European journal of cancer Issue: Volume 147(2021) Page Start: 128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study. Issue 13 (1st May 2021) Authors: Haffner, Ivonne; Schierle, Katrin; Raimúndez, Elba; Geier, Birgitta; Maier, Dieter; Hasenauer, Jan; Luber, Birgit; Walch, Axel; Kolbe, Katharina; Riera Knorrenschild, Jorge; Kretzschmar, Albrecht; Rau, Beate; Fischer von Weikersthal, Ludwig; Ahlborn, Miriam; Siegler, Gabriele; Fuxius, Stefan; Dec... Journal: Journal of clinical oncology Issue: Volume 39:Issue 13(2021) Page Start: 1468 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Impact of age on efficacy and early mortality of initial sequential treatment versus upfront combination chemotherapy in patients with metastatic colorectal cancer: a subgroup analysis of a phase III trial (AIO KRK0110, XELAVIRI study). (September 2020) Authors: Kurreck, Annika; Heinemann, Volker; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kaiser, Florian; Uhlig, Jens; Schenk, Michael; Freiberg-Richter, Jens; Peuser, Bettina; Denzlinger, Claudio; Graeven, Ullrich; Schwaner, Ingo; Stahler, Arndt; Heinrich, Kathrin; Jung, Andreas; Held, Swantje; von ... Journal: European journal of cancer Issue: Volume 137(2020) Page Start: 81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Impact of hand-foot skin reaction on treatment outcome in patients receiving capecitabine plus erlotinib for advanced pancreatic cancer: A subgroup analysis from AIO-PK0104. (July 2015) Authors: Kruger, Stephan; Boeck, Stefan; Heinemann, Volker; Laubender, Ruediger P.; Vehling-Kaiser, Ursula; Waldschmidt, Dirk; Kettner, Erika; Märten, Angela; Winkelmann, Cornelia; Klein, Stefan; Kojouharoff, Georgi; Gauler, Thomas C.; Fischer von Weikersthal, Ludwig; Clemens, Michael R.; Geissler, Michae... Journal: Acta oncologica Issue: Volume 54:Number 7(2015) Page Start: 993 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗